Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
51.6M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
10.5M
-
Shares change
-
+7.77M
-
Total reported value, excl. options
-
$47.7M
-
Value change
-
+$35.4M
-
Put/Call ratio
-
0.11
-
Number of buys
-
23
-
Number of sells
-
-16
-
Price
-
$4.55
Significant Holders of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) as of Q1 2024
51 filings reported holding ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share as of Q1 2024.
ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.5M shares
of 51.6M outstanding shares and own 20.34% of the company stock.
Largest 10 shareholders include Propel Bio Management, LLC (2.45M shares), Sofinnova Investments, Inc. (1.52M shares), VANGUARD GROUP INC (948K shares), ADAR1 Capital Management, LLC (875K shares), Altium Capital Management LP (835K shares), Nantahala Capital Management, LLC (654K shares), CVI Holdings, LLC (567K shares), Alyeska Investment Group, L.P. (471K shares), Shay Capital LLC (450K shares), and Long Focus Capital Management, LLC (248K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.